44th week of 2019 patent applcation highlights part 9 |
Patent application number | Title | Published |
20190328678 | NANOSPUN HEMP-BASED MATERIALS | 2019-10-31 |
20190328679 | UNIFORM FILMS FOR RAPID-DISSOLVE DOSAGE FORM INCORPORATING ANTI-TACKING COMPOSITIONS | 2019-10-31 |
20190328680 | Transdermal Therapeutic System with a Low Tendency to Spontaneously Crystallize | 2019-10-31 |
20190328682 | SLOW INTRAVENTRICULAR DELIVERY | 2019-10-31 |
20190328683 | RAPIDLY IMPROVING VASCULAR CONDITIONS BY ADMINISTERING VITAMIN K | 2019-10-31 |
20190328684 | COMPOSITION AND METHOD FOR TREATING NEUROLOGICAL DISEASE | 2019-10-31 |
20190328685 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING IMMUNE DISEASES OR INFLAMMATORY DISEASES, CONTAINING BIGUANIDE DERIVATIVE COMPOUND AS ACTIVE INGREDIENT | 2019-10-31 |
20190328686 | TREATMENT OF MODERATE AND SEVERE GASTROPARESIS | 2019-10-31 |
20190328687 | Antibacterial Compounds | 2019-10-31 |
20190328688 | TOPICAL FORMULATIONS AND TREATMENTS | 2019-10-31 |
20190328689 | MAGNESIUM THREONATE COMPOSITIONS AND USES THEREOF | 2019-10-31 |
20190328690 | METHODS FOR TREATING C-MET-DEPENDENT CANCERS | 2019-10-31 |
20190328691 | ANTIBIOTIC THERAPY | 2019-10-31 |
20190328692 | DEUTERATED ANALOGS OF D-SERINE AND USES THEREOF | 2019-10-31 |
20190328693 | CREATINE ORAL SUPPLEMENTATION USING CREATINE HYDROCHLORIDE SALT | 2019-10-31 |
20190328694 | COMPOSITION FOR PROMOTING SKELETAL MUSCLE ACTIVITY VIA INDUCTION OF MITOCHONDRIAL BIOGENESIS COMPRISING OF AZELAIC ACID AS AN ACTIVE INGREDIENT | 2019-10-31 |
20190328695 | ORAL COMPOSITION WITH IMMUNOMODULATING EFFECT ON NATURAL KILLER CELLS | 2019-10-31 |
20190328696 | FATTY ACID FORMULATIONS AND METHODS OF USE THEREOF | 2019-10-31 |
20190328697 | Animal Feeds and Feed Premixes Containing Betaine Hydrochloride and a Phytase | 2019-10-31 |
20190328698 | ESTERS FOR TREATMENT OF OCULAR INFLAMMATORY CONDITIONS | 2019-10-31 |
20190328699 | INGESTIBLE COMPOSITIONS SYSTEM AND METHOD | 2019-10-31 |
20190328700 | METHODS OF TREATING RESPIRATORY SYNCYTIAL VIRUS INFECTIONS | 2019-10-31 |
20190328701 | METHOD FOR ACTIVATING ENERGY METABOLISM IN MUSCLE CELLS BY ADMINISTERING TO HUMAN BEINGS AT LEAST ONE ACTIVE SUBSTANCE COMPRISING METHOXYFLAVONE | 2019-10-31 |
20190328702 | COMBINATION OF UNSAPONIFIABLE LIPIDS COMBINED WITH POLYPHENOLS AND/OR CATECHINS FOR THE PROTECTION, TREATMENT AND REPAIR OF CARTILAGE IN JOINTS OF HUMANS AND ANIMALS | 2019-10-31 |
20190328703 | BIOLOGICAL ENHANCER | 2019-10-31 |
20190328704 | SUPER-OXIDE DISMUTASE MIMETICS | 2019-10-31 |
20190328705 | IMMUNOSUPPRESSANT FORMULATION | 2019-10-31 |
20190328706 | COMPOSITIONS COMPRISING AN INTEGRIN INHIBITOR AND AGENTS WHICH INTERACT WITH A CHEMOKINE AND METHODS OF USE THEREOF | 2019-10-31 |
20190328707 | METHOD OF DOSING AND USE OF SOFT ANTICHOLINERGIC ESTERS | 2019-10-31 |
20190328708 | METHOD FOR ADMINISTRATION | 2019-10-31 |
20190328709 | CASPASE-1 INHIBITION AND USES THEREOF FOR PREVENTION AND TREATMENT OF NEUROLOGICAL CONDITIONS | 2019-10-31 |
20190328710 | SYNERGISTIC COMPOSITION FOR INHIBITING ADVANCED GLYCATION END PRODUCT CROSSLINKING | 2019-10-31 |
20190328711 | MEDICAL TREATMENT COMPRISING ENTERAL ADMINISTRATION OF EDARAVONE | 2019-10-31 |
20190328712 | TREATMENT COMPRISING ORAL OR GASTRIC ADMINISTRATION OF EDARAVONE | 2019-10-31 |
20190328713 | ORAL PREPARATION OF GLUCOKINASE ACTIVATOR AND PREPARATION METHOD THEREFOR | 2019-10-31 |
20190328714 | MAZINDOL COMBINATION IN THE TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY | 2019-10-31 |
20190328715 | ANTIGEN-DRIVEN DETECTION AND TREATMENT OF COCCIDIOIDOMYCOSIS | 2019-10-31 |
20190328716 | LIPOSOMAL FORMULATIONS OF AMIDINE SUBSTITUTED BETA-LACTAM COMPOUNDS FOR USE IN THE TREATMENT OF BACTERIAL INFECTIONS | 2019-10-31 |
20190328717 | COMPOSITIONS COMPRISING TACROLIMUS FOR THE TREATMENT OF INTRAOCULAR INFLAMMATORY EYE DISEASES | 2019-10-31 |
20190328718 | Medicaments and Uses in Treatment of Cancer and other Pathological Conditions Associated with Aging | 2019-10-31 |
20190328719 | METHODS OF TREATING DEVELOPMENTAL DISORDERS AND/OR SEIZURE DISORDERS WITH FLUPIRTINE | 2019-10-31 |
20190328720 | INHIBITORS OF DIHYDROCERAMIDE DESATURASE FOR TREATING DISEASE | 2019-10-31 |
20190328721 | METHOD OF ACTIVATING DENDRITIC CELLS | 2019-10-31 |
20190328722 | COMBINATION, APPLICATION THEREOF AND TREATMENT METHOD | 2019-10-31 |
20190328723 | Novel Regimens of Tafenoquine for Prevention of Malaria in Malaria-Naive Subjects | 2019-10-31 |
20190328724 | NOVEL METHODS OF USE OF TETRAHYDROBERBERINE (THB) | 2019-10-31 |
20190328726 | COMPOSITIONS AND METHODS FOR MINIMIZING OR REVERSING AGONIST-INDUCED DESENSITIZATION | 2019-10-31 |
20190328727 | METHOD OF TREATING CANCER ASSOCIATED WITH A RAS MUTATION | 2019-10-31 |
20190328728 | CO-SPRAY DRYING OF CIPROFLOXACIN AND COLISTIN AND THE USES THEREOF | 2019-10-31 |
20190328729 | Uses of Bcl-2 Antagonists for Treating Cancer and Diagnostics Related Thereto | 2019-10-31 |
20190328730 | PREVENTING OR TREATING AGENT FOR GLAUCOMA | 2019-10-31 |
20190328731 | LIPOSOMAL CIPROFLOXACIN FORMULATIONS WITH ACTIVITY AGAINST NON-TUBERCULOUS MYCOBACTERIA | 2019-10-31 |
20190328732 | TARGET GENES IN MYC-DRIVEN NEOPLASIA | 2019-10-31 |
20190328734 | Use of Sanglifehrin Macrocyclic Analogues as Anticancer Compounds | 2019-10-31 |
20190328735 | Fused Bicyclic 2,4-Diaminopyrimidine Derivative as a Dual ALK and FAK Inhibitor | 2019-10-31 |
20190328736 | Methods Of Treating Dyskinesia And Related Disorders | 2019-10-31 |
20190328737 | PHARMACEUTICAL FORMULATION | 2019-10-31 |
20190328738 | METHOD FOR INCREASING CELL PROLIFERATION IN PANCREATIC BETA CELLS, TREATMENT METHOD, AND COMPOSITION | 2019-10-31 |
20190328739 | TREATMENT OF HIDRADENITIS SUPPURATIVA USING JAK INHIBITORS | 2019-10-31 |
20190328740 | Cancer Treatment Targeted to Tumor Adaptive Responses to Protein Synthesis Stress | 2019-10-31 |
20190328741 | TREATING EXTRAPYRAMIDAL SYNDROME USING TRAPIDIL | 2019-10-31 |
20190328742 | TELODENDRIMERS WITH RIBOFLAVIN MOIETIES AND NANOCARRIERS AND METHODS OF MAKING AND USING SAME | 2019-10-31 |
20190328743 | EZH2 INHIBITORS FOR TREATING CANCER | 2019-10-31 |
20190328744 | NOVEL COMPOUNDS | 2019-10-31 |
20190328745 | NOVEL METHODS | 2019-10-31 |
20190328746 | FENOLDOPAM TOPICAL FORMULATIONS FOR TREATING SKIN DISORDERS | 2019-10-31 |
20190328747 | COMBINATIONS INCLUDING ABX196 FOR THE TREATMENT OF CANCER | 2019-10-31 |
20190328748 | PHOSPHAPLATIN COMPOUNDS AS THERAPEUTIC AGENTS FOR TREATMENT OF BONE OR BLOOD CANCERS | 2019-10-31 |
20190328749 | FORMULATION OF LONG-ACTING LEVONORGESTREL BUTANOATE INJECTABLE DEPOT SUSPENSION | 2019-10-31 |
20190328750 | TREATMENT OF DEMYELINATING DISEASES | 2019-10-31 |
20190328751 | LOW DOSE COMPOSITIONS OF ARAMACHOL SALTS | 2019-10-31 |
20190328752 | COMPOUNDS FOR THE TREATMENT OF NIEMANN-PICK DISEASE TYPE C1 | 2019-10-31 |
20190328753 | COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES | 2019-10-31 |
20190328754 | VITAMIN D3, HEAT SHOCK PROTEINS, AND GLUTATHIONE FOR THE TREATMENT OF CHRONIC INFLAMMATION AND CHRONIC DISEASES | 2019-10-31 |
20190328755 | METHODS OF TREATING COMPLEX REGIONAL PAIN SYNDROME (CRPS) OR SYMPTOMS COMPRISING ADMINISTRATION OF NERIDRONIC ACID | 2019-10-31 |
20190328756 | Hydrogen Sulphide Compounds | 2019-10-31 |
20190328757 | INTRATUMORAL VEIN-FORMATION PROMOTING AGENT | 2019-10-31 |
20190328758 | METHODS OF TREATING MITOCHONDRIAL DYSFUNCTION | 2019-10-31 |
20190328759 | PARENTERAL FORMULATIONS FOR ADMINISTERING MACROLIDE ANTIBIOTICS | 2019-10-31 |
20190328760 | METHODS OF TREATMENT OF VIRAL INFECTION AND USES OF ANTI-HSC70 INHIBITORS | 2019-10-31 |
20190328761 | METHODS FOR ENHANCING VASCULAR DENSITY | 2019-10-31 |
20190328762 | COMBINATIONS OF PD-1 ANTAGONISTS AND CYCLIC DINUCLEOTIDE STING AGONISTS FOR CANCER TREATMENT | 2019-10-31 |
20190328763 | A LIPID NANOPARTICLE FOR CARRYING ANTISENSE OLIGONUCLEOTIDES INHIBITING BCL-2 AND METHOD FOR PREPARING THE SAME | 2019-10-31 |
20190328764 | PREVENTING AND TREATING AMYLOID- BETA DEPOSITION BY STIMULATION OF INNATE IMMUNITY | 2019-10-31 |
20190328765 | METHODS FOR TREATING PATIENTS HAVING SINUSOIDAL OBSTRUCTION SYNDROME | 2019-10-31 |
20190328766 | COMPOSITIONS AND METHODS FOR SUPPRESSING MSUT2 | 2019-10-31 |
20190328767 | Use Of Polyinosinic-polycytidylic Acid Compositions In Treatment Of Malignant Effusion | 2019-10-31 |
20190328768 | MOLECULAR ADJUVANTS FOR ENHANCED CYTOSOLIC DELIVERY OF ACTIVE AGENTS | 2019-10-31 |
20190328769 | MRNA FUNCTIONALIZATION METHOD | 2019-10-31 |
20190328770 | COMPOSITIONS OF SMAD7 ANTISENSE OLIGONUCLEOTIDE AND METHODS OF TREATING OR PREVENTING PSORIASIS | 2019-10-31 |
20190328771 | METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON | 2019-10-31 |
20190328772 | OPHTHALMIC COMPOSITIONS COMPRISING A CYCLODEXTRIN AS SOLE ACTIVE AGENT | 2019-10-31 |
20190328773 | SODIUM CHLORITE COMPOSITIONS WITH ENHANCED ANTI-MICROBIAL EFFICACY AND REDUCED TOXICITY | 2019-10-31 |
20190328774 | ELECTROCHEMICAL GASOTRANSMITTER GENERATING COMPOSITIONS AND METHODS OF USING SAME AND DRESSINGS AND TREATMENT SYSTEMS INCORPORATING SAME | 2019-10-31 |
20190328775 | MAGNESIUM CHLORIDE COMPOSITION FOR DERMATOLOGICAL USE | 2019-10-31 |
20190328776 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS | 2019-10-31 |
20190328777 | NON-PYROGENIC PREPARATION COMPRISING NANOPARTICLES SYNTHESIZED BY MAGNETOTACTIC BACTERIA FOR MEDICAL OR COSMETIC APPLICATIONS | 2019-10-31 |
20190328778 | USE OF A COMBINATION OF D-ASPARTIC AND L-ASPARTIC ACIDS OR SALTS THEREOF FOR THE TREATMENT OF MALE INFERTILITY | 2019-10-31 |
20190328779 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING BRAIN CANCER INCLUDING CRYSTAL POLYMORPH OF TETRAARSENIC HEXOXIDE, AND METHOD FOR PREPARING SAME | 2019-10-31 |
20190328780 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING BREAST CANCER INCLUDING CRYSTALLINE POLYMORPH OF TETRAARSENIC HEXOXIDE, AND METHOD FOR PRODUCING SAME | 2019-10-31 |